Delivery Order SPE2DB25D3020-SPE2DB25FWJSZ
- Not listed
- The Defense Logistics Agency awarded a $3,345.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Armodafinil 250 mg tablets in 30-count units. This firm fixed-price delivery order, valued at $1,984.17, represents a non-competitive set-aside award and is scheduled for completion by August 20, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,672.50. The contract was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and involves no set-aside designation. Performance will be conducted at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.24 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,672.35 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Armodafinil 250mg (30-count packages) with a ceiling value of $1,696.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for ultimate completion on July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,566.44 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract. The delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award utilizes no set-aside designation and was competitively awarded. This delivery...
- The Defense Logistics Agency awarded a $26,200 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 150 mg tablets of armodafinil. The order is for 30 tablets to be delivered to a facility in Conshohocken, Pennsylvania by August 17, 2023. Armodafinil is a wakefulness-promoting agent commonly used to treat excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorder. The Defense Logistics Agency manages the global supply chain for the...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.45 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency Troop Support Medical awarded a $2,250 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250mg armodafinil tablets. Under this contract, Amerisourcebergen will deliver 30 tablets of armodafinil to a location in Conshohocken, Pennsylvania. The delivery order was awarded on July 25, 2023 and has a period of performance concluding on July 26, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWJSZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,655.82, with completion scheduled for July 29, 2025. This non-set-aside competitive award was issued on July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Armodafinil is a wakefulness-promoting agent commonly used to treat narcolepsy, obstructive sleep apnea, and shift work sleep disorder, indicating this delivery supports military or veteran healthcare pharmaceutical needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills federal supply requirements through competitive awards covering an extensive range of medications and medical supplies across multiple therapeutic domains. The company's contract awards with DLA demonstrate its established capability to meet federal procurement requirements and support Defense Health Agency and other government healthcare systems through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 7/28/25 |